Provided By PR Newswire
Last update: Jul 22, 2025
NEW YORK, July 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") (NASDAQ: GILD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:GILD (7/23/2025, 2:42:01 PM)
113.08
+2.91 (+2.64%)
Find more stocks in the Stock Screener